Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. EROC
4. IQMX
5. SEER
6. FRBT
7. MSTR
8. SNDK
9. NVDA
10. SPGI

Go back to Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
(NASDAQ: PPCB) Delayed: 1.88 --0 (-0%)
Previous Close $1.88    52 Week High $ 
Open $1.79    52 Week Low $ 
Day High $1.88    P/E N/A 
Day Low $1.88    EPS $ 
Volume 153       

(NASDAQ: PPCB) Delayed: 1.88 --0 (-0%)
Previous Close $1.88    52 Week High $ 
Open $1.79    52 Week Low $ 
Day High $1.88    P/E N/A 
Day Low $1.88    EPS $ 
Volume 153